PhaseBio Pharmaceuticals (PHAS) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PHAS Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVelia Therapeutics Appoints Michael York as Chief Business Officerfinance.yahoo.com - December 14 at 8:55 AMAlcami Announces CEO Transitionfinance.yahoo.com - June 5 at 10:33 AM8-K: PhaseBio Pharmaceuticals Incmarketwatch.com - May 12 at 2:46 AMAbsci Corporation: Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Resultsfinanznachrichten.de - March 31 at 6:59 PMBioCryst Pharmaceuticals, Inc.: BioCryst Appoints Dr. Nancy Hutson as Chair of the Boardfinanznachrichten.de - March 31 at 1:59 PMBioCryst Appoints Dr. Nancy Hutson as Chair of the Boardfinance.yahoo.com - March 31 at 8:59 AMCardiomyopathy Medication Market Size and Forecast till 2031marketwatch.com - March 22 at 1:16 PMCardiomyopathy Medication Market Emerging Demand and Drive Growth by 2028 with Top Countries Datamarketwatch.com - February 28 at 1:24 PMSFJ Pharmaceuticals Announces Closing of Transfer of Bentracimab Assets from PhaseBio Pharmaceuticalsbenzinga.com - January 17 at 12:24 PMBankruptcy court approves PhaseBio's $32.9M asset transfer dealbizjournals.com - January 5 at 7:47 PMBankrupt PhaseBio Identifies Chiesi as Lead Bidder for Bentracimab Assetsmarketwatch.com - November 8 at 12:22 AMShort Volatility Alert: PhaseBio Pharmaceuticals, Inc.benzinga.com - November 4 at 2:57 PMWhy Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Sessionmsn.com - November 2 at 6:43 PMWhy Goodyear Tire & Rubber Shares Are Trading Lower; Here Are 24 Stocks Moving Premarketmsn.com - November 1 at 12:30 PMPhaseBio Pharmaceuticals 10% Owner Trades Company's Stockbenzinga.com - October 27 at 4:54 PMPhaseBio Files for Bankruptcy Following Blackstone-Backed Partner’s Lawsuitwsj.com - October 25 at 5:37 AMPhaseBio files for bankruptcy, has a potential deal to sell its assets for up to $100Mbizjournals.com - October 25 at 5:37 AMPhaseBio Pharma Files For Chapter 11 Bankruptcy Protectionnasdaq.com - October 24 at 12:07 PMPhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Codefinance.yahoo.com - October 24 at 12:07 PMPhaseBio files for bankruptcy, has a potential deal to sell its assets for up to $60Mfinance.yahoo.com - October 24 at 12:07 PMPhaseBio Files for Bankruptcy With Plans to Sell Assetsfinance.yahoo.com - October 24 at 12:07 PMCash-strapped PhaseBio sued by drug development partner in dispute over experimental therapybizjournals.com - October 19 at 4:16 PMPhaseBio Might Have To Return Global Rights To Its Lead Programfinance.yahoo.com - October 6 at 1:48 AMHypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsightfinance.yahoo.com - October 3 at 3:48 PMWhy an East Bay company wants control of its partner's blood thinner antidotefinance.yahoo.com - September 29 at 8:26 PMPhaseBio sinks ~67% after getting transfer notice for lead drug bentracimab's businessseekingalpha.com - September 28 at 2:28 PMPhaseBio Pharmaceuticals (PHAS) Investor Presentation - Slideshowseekingalpha.com - August 14 at 7:12 PMPhaseBio Pharmaceuticals (PHAS) Reports Q2 Loss, Lags Revenue Estimatesfinance.yahoo.com - August 12 at 1:43 PMPhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlightsfinance.yahoo.com - August 12 at 8:42 AMPulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsightfinance.yahoo.com - August 1 at 3:51 PMStrong week for PhaseBio Pharmaceuticals (NASDAQ:PHAS) shareholders doesn't alleviate pain of three-year lossfinance.yahoo.com - July 9 at 6:48 PMPhaseBio Pharmaceuticals: Q1 Earnings Insightsbenzinga.com - May 16 at 5:08 PMPhaseBio Pharmaceuticals GAAP EPS of -$0.23 beats by $0.43seekingalpha.com - May 16 at 9:18 AMPhaseBio to seek FDA approval for clotting agent in 4Q 2022seekingalpha.com - May 16 at 9:18 AMPhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlightsfinance.yahoo.com - May 16 at 9:18 AMPhaseBio Pharmaceuticals (PHAS) Reports Q1 Loss, Misses Revenue Estimatesfinance.yahoo.com - May 16 at 9:18 AMPHAS PhaseBio Pharmaceuticals, Inc.seekingalpha.com - May 14 at 9:56 PMNeedham Estimates PhaseBio Pharma's Bentracimab Market Opportunity Of Up To $1.5Bfinance.yahoo.com - April 18 at 8:59 PMPhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conferencenz.finance.yahoo.com - April 7 at 4:05 PMPhaseBio reports full results of phase 2b trial of bentracimab to reverse ticagrelor's antiplatelet activityseekingalpha.com - April 4 at 11:21 AMPhaseBio Announces Positive Results from Phase 2b Trial for Bentracimabfinance.yahoo.com - April 4 at 11:21 AMPhaseBio Pharmaceuticals (NASDAQ:PHAS) Price Target Cut to $10.00marketbeat.com - March 28 at 8:28 AMNeedham Maintains Buy on PhaseBio Pharmaceuticals, Lowers Price Target to $10benzinga.com - March 28 at 7:14 AMLooking Into PhaseBio Pharmaceuticals's Return On Capital Employedbenzinga.com - March 25 at 4:22 PMPhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlightsfinance.yahoo.com - March 24 at 4:10 PMPhaseBio Pharmaceuticals Announces Bentracimab Manufacturing Updatefinance.yahoo.com - March 8 at 12:08 PMPhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care Conferencefinance.yahoo.com - February 24 at 8:53 PMPhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific Sessionfinance.yahoo.com - February 10 at 3:53 PMPhaseBio Pulls Plug On Mid-Stage Hypertension Assetfinance.yahoo.com - December 21 at 8:27 PMPhaseBio Pharmaceuticals (NASDAQ:PHAS) adds US$20m to market cap in the past 7 days, though investors from a year ago are still down 45%finance.yahoo.com - December 13 at 3:25 PM Get PhaseBio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. PHAS Media Mentions By Week PHAS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAS News Sentiment▼0.000.33▲Average Medical News Sentiment PHAS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAS Articles This Week▼00▲PHAS Articles Average Week Get PhaseBio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GOVX News Today ARDS News Today NEXI News Today MBIO News Today BCEL News Today SXTP News Today EVOK News Today PHIO News Today ARAV News Today RNAZ News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHAS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PhaseBio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
